Compass Therapeutics, Inc.

CMPX

Compass Therapeutics, Inc.’s revenue for fiscal 2024 (year ended December 2024) was $850,000.00.

Quarter to June 2026, against a year earlier

0.76 0.08 +11.76%

Follow CMPX

Alert me

Overview

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
ROE Full definition →	(56.66%)	(45.95%)	(41.29%)	(37.82%)	+8 more TTM periods Free account
ROA Full definition →	(47.87%)	(40.50%)	(36.94%)	(34.60%)
ROIC Full definition →	0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →	(44.49%)	(36.74%)	(33.93%)	(31.51%)
Average Days of Receivables Full definition →	—	—	—	—
Free Cash Flow per Share Full definition →	(0.30)	(0.29)	(0.31)	(0.27)
Free Cash Flow Full definition →	(56.37)	(53.29)	(49.17)	(45.08)
Capital Expenditures Full definition →	(0.26)	(0.09)	(0.02)	(0.02)
Other line items
Cash ROIC Full definition →	(16.30%)	(13.98%)	(12.12%)	(10.49%)
Accounts Payable Turnover Full definition →	0.00	0.00	0.00	0.00
Average Days of Payables Full definition →	0.00	0.00	0.00	0.00
Tax Rate Full definition →	0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Share Based Compensation of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Operating CF/Net income Full definition →	0.76	0.78	0.74	0.68
Depreciation/Fixed assets Full definition →	(1.51)	(2.54)	(1.97)	6.00
Capex/Depreciation Full definition →	0.54	0.21	0.12	(0.03)
Revenue per Share Full definition →	0.00	0.00	0.00	0.00
Operating CF per Share Full definition →	(0.30)	(0.29)	(0.31)	(0.27)
Capex per Share Full definition →	0.00	0.00	0.00	0.00
Capex to Sales Full definition →	0.00	0.00	0.00	0.00

Columns are period end dates · fundamentals updated 2 Nov 2026